Clinical and Neuroimaging Findings in MOGAD-MRI and OCT
Clin Exp Immunol 206:266-281, Bartels,F.,et al, 2021
Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020
A Patient with a History of Weight Loss Presenting with Seizures
Neurol 95:e2038-e2042, Tang, G. & Benavides, D.R., 2020
The role of infarct location in patients with DWI-ASPECTS 0-5 acute stroke treated with thrombectomy
Neurol 95:e3344-e3354,1078, Panni, P.,et al, 2020
Fat Embolism Syndrome in Sickle Cell Disease
J Clin Med 9:1-12, Tsitsikas, D.A.,et al, 2020
Three Territory Sign
Neurol Clin Pract 9:124-128, Nouh, A.M.,et al, 2019
"Better Explanations" in Multiple Sclerosis Diagnostic Workup
Neurol 92:e2527-e2537, Calabrese, M.,et al, 2019
Mapping the Supratentorial Cerebral Arterial Territories Using 1160 Large Artery Infarcts
JAMA Neurol 76:72-80, Kim, D-E.,et al, 2019
Diagnostic Tools for Immune Causes of Encephalitis
Clin Microbiol Infect 25:431-436, Lascano, A.M.,et al, 2019
Surviving Cerebral Malaria
Neurol 91:978-979, Wijdicks, E.F.M. & Park, J.G., 2018
Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia: An MRI Study of 16 French Cases
AJNR 39:1657-1661, Codjia, P.,et al, 2018
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018
Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018
Mixed-Location Cerebral Hemorrhage/Microbleeds
Neurol 90:e119-e126, Pasi, M.,et al, 2018
Gasperini Syndrome
Neurol 90:e261, Lorio, R., 2018
Supplementary Motor Area Stroke Mimicking Functional Disorder
Stroke 49:e28-e30, Mathew, P.,et al, 2018
Cerebral Fat Embolism Syndrome in Sickle Cell Disease Without Evidence of Shunt
eNeurologicSci 14:19-20, Nathan, C.L.,et al, 2018
Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017
Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017
Evolution of DWI lesions in Cerebral Amyloid Angiopathy
Neurol 89:2136-2142, Van Veluw, S.J.,et al, 2017
Imaging Characteristics of Venous Parenchymal Abnormalities
Stroke 48:3258-3265, Arnoux, A.,et al, 2017
Glial Fibrillary Acidic Protein Immunoglobulin G as Biomarker of Autoimmune Astrocytopathy: Analysis of 102 Patients
Ann Neurol 81:298-309, Flanagan, E.P.,et al, 2017
Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017
Distribution of Lacunes in Cerebral Amyloid Angiopathy and Hypertensive Small Vessel Disease
Neurol 88:2162-2168, Pasi, M.,et al, 2017
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017
Have Clinicians Adopted the Use of Brain MRI for Patients with TIA and Minor Stroke?
Neurol 88:237-244, Chaturvedi, S.,et al, 2017
Characteristics in Limbic Encephalitis with Anti-Adenylate Kinase 5 Autoantibodies
Neurol 88:514-524,508, Do, L. & Chanson, E., 2017
The Contemporary Spectrum of Multiple Sclerosis Misdiagnosis
Neurol 87:1393-1399, Solomon, A.J.,et al, 2016
Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016
Pseudoradial Nerve Palsy Caused by Acute Ischemic Stroke
J Invest Med Case Report doi:10.1177/2324709616658310, Tahir, H.,et al, 2016
Marburgs Variant of Multiple Sclerosis with Extensive Brain Lesions
Int J Neurol Neurother doi:10.23937/2378-3001/2/1/1027, Ludwig, A.,et al, 2015
Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments
Stroke 46:2987-2990, Kamal, N.,et al, 2015
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015
Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014
Evaluation of Cryptogenic Stroke with Advanced Diagnostic Techniques
Stroke 45:1186-1194, Bang, O.Y.,et al, 2014
DWI Reversal is Associated with Small Infarct Volume in Patient with TIA and Minor Stroke
AJNR 35:660-666, Asdaghi, N.,et al, 2014
Dynamic MR Imaging Patterns of Cerebral Fat Embolism: A Systematic Review with Illustrative Cases
AJNR 35:1052-1057, Kuo, K.H.,et al, 2014
IgG4-Related Hypertrophic Pachymeningitis
JAMA Neurol 71:785-793, Lu, L.X.,et al, 2014
Amyloid-Beta Related Angiitis of the Central Nervous System: Case Report and Topic Review
Front Neurol 5:1-4, Nouh, A.,et al, 2014
Small Strokes Causing Severe Vertigo
Neurol 83:169-173, Tehrani, A.S.S.,et al, 2014
CD49d Antisense Drug ATL1102 Reduces Disease Activity in Patients with Relapsing-Remitting MS
Neurol 83:1780-1788, Limmroth, V.,et al, 2014
Sensitivity and Specificity of the Hyperdence Artery Sign for Arterial Obstruction in Acute Ischemic Stroke
Stroke 46:102-107, Mair, G.,et al, 2014
Enhancing Brain Lesions after Endovascular Treatment of Aneurysms
AJNR 35:1954-1958, Cruz, J.P.,et al, 2014
Hemiballism in a Patient with Parietal Lobe Infarction
Neurol 80:e22, Wu, M.C.,et al, 2013
Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013
Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013
Brain Injury Patterns in Hypoglycemia in Neonatal Encephalopathy
AJNR 34:1458-1461, Wong, D.S.T.,et al, 2013
Extending the KCNQ2 encephalopathy Spectrum
Neurol 81:1697-1703, Weckhuysen, S.,et al, 2013
Computed Tomography Angiography in Hyperacute Ischemic Stroke
Stroke 44:1480-1488, Mortimer, A.,et al, 2013